Since IR and systemic hypertension are predictors of advanced fibrosis in obese patients with NAFLD, Dixon et al. hypothesized that high AT and TGF-β1 producing genotypes increase the risk of liver fibrosis in obese subjects with NAFLD. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.